ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,326Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 393

$706K Total Retail Price of All Prescriptions

Rank: 23 out of 393

802 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 802 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

23% of this provider’s 802 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 19,285 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$32 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 1,420 1,260 1 1
LISINOPRIL 1,125 1,042 2 2
LEVOTHYROXINE SODIUM 1,119 1,001 3 3
OMEPRAZOLE 1,030 852 4 6
ALENDRONATE SODIUM 933 914 5 16
HYDROCODONE-ACETAMINOPHEN 861 679 S3 6 5
AMLODIPINE BESYLATE 576 525 7 4
GABAPENTIN 528 407 8 15
METFORMIN HCL 513 453 9 7
FUROSEMIDE 487 455 10 8
HYDROCHLOROTHIAZIDE 458 420 11 10
LOVASTATIN 419 397 12 14
METOPROLOL SUCCINATE 384 348 13 22
METOPROLOL TARTRATE 381 338 14 9
ATENOLOL 342 326 15 13
WARFARIN SODIUM 316 300 16 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 289 247 17 24
DONEPEZIL HCL 281 266 18 34
CITALOPRAM HBR 260 219 19 23
GLYBURIDE 254 244 R 20 46
RANITIDINE HCL 252 232 21 29
VENTOLIN HFA 243 191 22 42
LOSARTAN-HYDROCHLOROTHIAZIDE 239 205 23 31
LOSARTAN POTASSIUM 215 187 24 12
CARVEDILOL 215 205 24 21
ALLOPURINOL 200 166 26 26
POTASSIUM CHLORIDE 195 177 27 20
TERAZOSIN HCL 189 182 28 38
TRIAMTERENE-HCTZ 188 165 29 49
ZOLPIDEM TARTRATE 167 125 30 11
ATORVASTATIN CALCIUM 164 144 31 19
AMITRIPTYLINE HCL 162 117 R 32 72
SERTRALINE HCL 158 137 33 28
KLOR-CON 10 157 130 34 113
GLIPIZIDE 152 145 35 32
OXYBUTYNIN CHLORIDE 150 137 36 90
DILTIAZEM ER 149 135 37 107
CLOPIDOGREL 146 134 38 33
ISOSORBIDE MONONITRATE ER 145 112 39 67
FLUTICASONE PROPIONATE 134 84 40 27
LANTUS SOLOSTAR 133 109 41 74
NAMENDA 132 132 42 59
TRAZODONE HCL 131 122 43 47
PLAVIX 131 122 43 51
OXYCODONE HCL-ACETAMINOPHEN 127 108 S2 45 54
NIFEDIPINE ER 126 125 46 91
SPIRIVA 120 104 47 41
OXYBUTYNIN CHLORIDE ER 119 119 48 122
TIZANIDINE HCL 118 92 49 97
NAPROXEN 113 75 50 85
IBUPROFEN 112 90 51 55
FLUOXETINE HCL 104 84 52 37
OXYCODONE-ACETAMINOPHEN 103 83 S2 53 71
PEN NEEDLE 103 77 53 81
MORPHINE SULFATE ER 102 45 S2 55 48
DIGOXIN 95 95 56 66
CARISOPRODOL 91 23 R 57 45
DILTIAZEM 24HR ER 87 79 58 129
ROPINIROLE HCL 86 51 59 121
VERAPAMIL ER 73 73 60 86
METFORMIN HCL ER 72 70 61 63
HYDRALAZINE HCL 72 72 61 64
FELODIPINE ER 69 69 63 130
CLONIDINE HCL 68 68 64 50
EVISTA 68 63 64 98
BENAZEPRIL HCL 68 68 64 40
GEMFIBROZIL 67 59 67 62
BACLOFEN 67 46 67 79
TAMSULOSIN HCL 66 53 69 25
OXYCODONE HCL 65 28 S2 70 36
NIFEDIAC CC 65 50 70 203
ENALAPRIL MALEATE 64 64 72 77
CIPROFLOXACIN HCL 61 55 73 57
PREDNISONE 60 52 74 65
PRAVASTATIN SODIUM 60 37 74 18
FINASTERIDE 58 58 76 60
ACTOS 55 52 77 78
FENOFIBRATE 54 42 78 43
VYTORIN 53 39 79 160
SYMBICORT 52 46 80 96
GLIMEPIRIDE 52 48 80 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.